Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.

PORTAGE, Michigan - Medical (TASE:PMCN) technology firm Stryker Corporation (NYSE:SYK), with a market capitalization of $149.59 billion, has announced an increase in its quarterly dividend. Today, the ...

Orthopedic Implants Market Trends 2025 Increase in the prevalence of orthopedic injuries or diseases such as arthritis and osteoarthritis & ...

Request To Download Free Sample of This Strategic Report @ Driving Forces Behind Growth: The exponential growth of the North America medical implant market is propelled by several key drivers.

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...

Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Argus analyst David Toung raised the firm’s price target on Stryker (SYK) to $450 from $410 and keeps a Buy rating on the shares. Argus expects ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Stryker (SYK – Research Report), with a price target of ...